MENU

BPTH Bio-Path Holdings Forecast, Technical & Fundamental Analysis

a clinical stage biotechnology company, which focuses on developing therapeutic products

Industry Biotechnology
BPTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
BPTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BPTH is expected to report earnings to rise 1,587.50% to -540 cents per share on March 08

Bio-Path Holdings BPTH Stock Earnings Reports
Q4'23
Est.
$-5.40
Q3'23
Beat
by $0.02
Q2'23
Missed
by $0.09
Q1'23
Missed
by $0.20
Q4'22
Missed
by $1.44
The last earnings report on November 15 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 84.89K shares outstanding, the current market capitalization sits at 2.88M.
A.I. Advisor
published General Information

General Information

a clinical stage biotechnology company, which focuses on developing therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4710 Bellaire Boulevard
Phone
+1 832 742-1357
Employees
10
Web
https://www.biopathholdings.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

BPTH and Stocks

Correlation & Price change

A.I.dvisor tells us that BPTH and GPCR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BPTH and GPCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPTH
1D Price
Change %
BPTH100%
-3.60%
GPCR - BPTH
24%
Poorly correlated
-11.37%
AFMD - BPTH
24%
Poorly correlated
-16.56%
TRML - BPTH
23%
Poorly correlated
-9.10%
XRTX - BPTH
23%
Poorly correlated
-2.61%
NERV - BPTH
22%
Poorly correlated
-4.37%
More